Medication Treatments | Addiction Professional Magazine Skip to content Skip to navigation

Medication Treatments

Study offers reasons why alcohol medication adherence poses challenge

February 15, 2018  |  Gary A. Enos, Editor
article
Research reveals several factors that influence the ability of patients with an alcohol use disorder to stay on a daily medication regimen, including intense cravings and a weekend danger.

Nurses, peers pivotal to health system's opioid disorder initiative

February 12, 2018  |  Gary A. Enos, Editor
article
Leaders at Christiana Care Health System say efforts to identify and address opioid use disorders in hospital settings should not be confined to the emergency room.

Addiction groups target primary care in effort to boost opioid crisis response

February 5, 2018  |  Gary A. Enos, Editor
article
Groups led by the American Academy of Addiction Psychiatry say primary care organizations need substance use disorder training that goes beyond simply certifying more prescribers.

Willing to go with what works

January 29, 2018  |  Tom Valentino, Senior Editor
article
From the 12 Steps to medication-assisted treatment, a majority of Quality of Life Survey respondents embrace solutions that click with clients.

Researchers explore medications' possible role in fighting methamphetamine

December 21, 2017  |  Gary A. Enos, Editor
news
Research at the University of Florida is focusing on sigma-1 receptor agonists as a possible drug intervention for individuals in treatment for methamphetamine addiction.

FDA approves once-monthly injectable buprenorphine product

December 1, 2017  |  Tom Valentino, Senior Editor
article
The FDA has approved a once-monthly injectable form of buprenorphine for the treatment of opioid use disorder, but clinicians are lukewarm on its use.

FDA seeks to encourage development of abuse-deterrent opioid formulations

November 24, 2017  |  Gary A. Enos, Editor
news
The Food and Drug Administration (FDA) this week announced several steps designed to remove barriers to access to abuse-deterrent formulations of opioids.

States eye adding gabapentin to controlled substance list

November 22, 2017  |  Rachael Zimlich, RN, Contributing Writer
article
Reports of increasing misuse of gabapentin, usually in combination with opioids or other drugs, have caught the attention of a number of state regulators.

Drug studies' results make case for access to all opioid dependence medications

November 16, 2017  |  Gary A. Enos, Editor
article
Recent efficacy and safety studies found comparable and encouraging results for buprenorphine and injectable naltrexone in the treatment of opioid dependence.

FDA clears electrical device to combat opioid withdrawal

November 15, 2017  |  Gary A. Enos, Editor
news
The Food and Drug Administration (FDA) today announced that an electrical stimulation device attached to the ear can be marketed for the treatment of symptoms of opioid withdrawal.

Hospital boosts opioid patients' rapid access to medication

November 14, 2017  |  Gary A. Enos, Editor
article
The experience of Boston Medical Center bolsters evidence that hospitalized patients with opioid use disorders can be successfully initiated on medication before discharge.

Record-setting amount of prescriptions collected on Take Back Day

November 7, 2017  |  Tom Valentino, Senior Editor
news
More than 456 tons of unwanted medications were collected for safe disposal during the U.S. Drug Enforcement Administration’s 14th Prescription Drug Take Back Day.

Pages

Subscribe to Medication Treatments